- Carlos Caldas, senior research associate (cc234@cam.ac.uk)
- University of Cambridge Department of Oncology, Addenbrooke's Hospital, Box 193, Cambridge CB2 2QQ
The recent announcement of cancer as the main cause of death in the United Kingdom comes at the end of two decades of exciting advances in understanding the basic biology of human tumours. It is now established that the development of neoplasia is due to accumulated genetic alterations in somatic cells. Identifying cell populations that share specific genetic alterations from samples of saliva, sputum, urine, stool, and blood is likely to be become a routine method of screening populations for common cancers. Genetic assessment will also be used to stage tumours and detect micrometastases. The correlation of specific profiles of genetic alterations with clinical outcome will help define prognosis more accurately and enable clinicians to target treatment more effectively.
Cancer as a disease of genetic alterations
The major discovery in cancer biology has been that tumorigenesis is a multistep process associated with accumulated genetic alterations in somatic cells. The progression of a tumour through preneoplasia to frank neoplasia and then invasion and metastasis is the result of successive rounds of clonal expansion of somatic cells that acquire a selective growth advantage as a result of mutations in genes that control cellular proliferation and death.1 Mutations result either in the activation of oncogenes, which promote cellular proliferation or inhibit cell death, or in the inactivation of tumour suppressor genes, which inhibit proliferation or promote cell death. To become a cancer cell, a normal cell needs to accumulate at least five or six of these mutations.1
Mutations occur at a higher rate in cancer cells because their genetic material (chromosomes or DNA) is intrinsically unstable.1 This genetic instability seems to be a “property” of cancer cells.1
Colorectal carcinoma is the best studied example of the genetic alterations that underlie human cancer.2 A normal mucosal cell with inactivation of a tumour suppressor gene called APC …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012